Human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) is a progressive disease of the CNS that causes weakness or paralysis of the …

Epidemiologic aspects of human T-lymphotropic virus type I (HTLV-I) infection have been
thoroughly studied over the course of approximately 25 years since its first description. The …

Background Accurate estimates of the risk of transfusion-transmitted infectious disease are
essential for monitoring the safety of the blood supply and evaluating the potential effect of …

Human T-cell leukemia virus type 1 (HTLV-1), the first human retrovirus to be discovered, is
present in diverse regions of the world, where its infection is usually neglected in health care …

Human T-lymphotropic virus 1 (HTLV-1) has infected human beings for thousands of years,
but knowledge about the infection and its pathogenesis is only recently emerging. The virus …

Blood transfusion and blood conservation (techniques or strategies to avoid the need for
blood) are complementary activities that constitute the clinical arena of transfusion medicine …

Human T-cell lymphotropic virus type I (HTLV-I) is the first human retrovirus to be associated
with malignant disease—namely, adult T-cell leukaemia/lymphoma. HTLV-I has also been …

Over the past 20 years, there has been a major increase in the safety of the blood supply, as
demonstrated by declining rates of posttransfusion infection and reductions in estimated …

Human T cell leukemia virus type 1 (HTLV-1) was the first discovered human retrovirus and
the etiologic agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical …

The deltaretroviruses human T cell lymphotropic virus type 1 (HTLV-1) and human T cell
lymphotropic virus type 2 (HTLV-2) have long been believed to differ from retroviruses in …